Experiences of adolescents and young adults with type 1 diabetes and chronically elevated glucose levels following the transition from multiple daily injections to advanced hybrid closed‐loop: A qualitative study
Authors' conclusion
Transition to AHCL therapy positively impacted diabetes management in adolescents and youth with chronically elevated glucose levels. It appears to create a window of opportunity in which youth may re-engage with diabetes management. Pseudo-hypoglycaemia can occur during the transition to AHCL. This could be a barrier to AHCL uptake and is likely to require individualised support.
Study context
- Population
- Adolescents and young adults aged 13–25 years with T1D and chronically elevated glucose (HbA1c ≥69 mmol/mol (8.5%); diabetes duration ≥1 year), previously on multiple daily injections (MDI); mean age 19.4 ± 4.3 years, mean baseline HbA1c 90 ± 25 mmol/mol (10.4 ± 4.5%)interviewed
- Participants
- 14 adolescents
- Outcome
- Experiences of using AHCL therapy
- Follow-up
- 3 months
Methodological detailssemi-structured interviews, qualitative content analysis, nested in single-arm prospective study
- Semi-structured interviews
- Qualitative content analysis
- Nested in single-arm prospective study
Main finding
As reported in the abstract
Themes
- Substantially improved glucose levels improved perceptions of overall health
- Features of advanced hybrid closed-loop (AHCL) aid in adoption and ongoing self-management
- Burden of care reduced through automation of insulin delivery
- Positive impacts on physical, mental and social well-being; minor frustrations overlooked because of vast benefits
Observational data: associations, not effects.
Safety
Transient pseudo-hypoglycaemia (hypoglycaemia symptoms with glucose in range 3.9-10 mmol/L, 70-180 mg/dL)
- Participants reporting transient pseudo-hypoglycaemia
- 4
Original publication
Experiences of adolescents and young adults with type 1 diabetes and chronically elevated glucose levels following the transition from multiple daily injections to advanced hybrid closed‐loop: A qualitative study. Diabet Med. Published 8 October 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →